Anticoagulant Therapy in Private Practice

Anticoagulant therapy in private practice.

THE DISCOVERY of heparin by McClean in 1916' and the identification of bishydroxycoumerin (Dicumarol) by Link and his co-workers in 1934 as the agent responsible for sweet clover disease in cattle,2 stimulated studies of the clinical use of anticoagulant therapy. The excellent work of Jorpes,3 Zilliacus,4 Barker5" 6 of the Mayo Clinic, and Wright7'8 of New York, and others,9' 10, n has crystall...

Anticoagulant therapy in pediatrics

Thromboembolic episodes are disorders encountered in both children and adults, but relatively more common in adults. However, the occurrence of venous thromboembolism and use of anticoagulants in pediatrics are increasing. Unfractionated Heparin (UH) is used as a treatment and prevention of thrombosis in adults and critically ill children. Heparin utilization in pediatric is limited by many fac...

Audit of anticoagulant therapy.

Computer assisted anticoagulant therapy.

The constantly workload increase has led to the development of Computerised Decision Support Systems (CDSS) for a better management of patient care. Many clinical situations have been investigated to verify the utility of CDSS: few have demonstrated stable effects. One area where success has been reported is the field of oral anticoagulation management. CDSS system has demonstrated to be able t...

Long-term anticoagulant therapy.

Experience with long-term anticoagulant therapy during the past seven years has been sumnmarized. This report is based on the records of 227 individuals treated as private or outpatient clinic patients for from four weeks to seven years. Where adequate laboratory facilities are available outpatient long-term therapy may be satisfactorily controlled by physicians familiar with the use of anticoa...